Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for MHTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
Date Value
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 4.705M
March 31, 2017 -4.705M
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.186M
September 30, 2015 0.138M
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 -1.974M
September 30, 2014 -0.06M
June 30, 2014 0.00
March 31, 2014 -1.487M
December 31, 2013 -0.11M
September 30, 2013 -0.02M
June 30, 2013 0.00
March 31, 2013 0.00
December 31, 2012 0.00
September 30, 2012 -0.18M
June 30, 2012 -0.15M
March 31, 2012 -0.30M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Tenax Therapeutics, Inc. -13.37M
Exicure, Inc. 0.00
Century Therapeutics, Inc. -0.311M
Absci Corp. -102.99M
Celularity, Inc. 0.21M